Study protocol for a randomised controlled double-blinded trial of the dose-dependent efficacy and safety of primaquine for clearance of gametocytes in children with uncomplicated falciparum malaria in Uganda
暂无分享,去创建一个
T. Bousema | C. Drakeley | N. White | M. Kamya | S. Yeung | S. Staedke | E. Webb | A. C. Eziefula
[1] W. Hawley,et al. The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: an open-label, randomized, controlled trial. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] T. Bousema,et al. Can field-based mosquito feeding assays be used for evaluating transmission-blocking interventions? , 2013, Trends in parasitology.
[3] L. Luzzatto,et al. Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common , 2012, Malaria Journal.
[4] A. Dondorp. Editorial Commentary: Single-Dose Primaquine as Gametocytocidal Treatment in Patients With Uncomplicated Falciparum Malaria , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] X. Su,et al. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. , 2012, The Lancet. Infectious diseases.
[6] T. Bousema,et al. Rationale for short course primaquine in Africa to interrupt malaria transmission , 2012, Malaria Journal.
[7] P. Garner,et al. Primaquine for reducing Plasmodium falciparum transmission. , 2012, The Cochrane database of systematic reviews.
[8] J. Cox,et al. Novel Vectors of Malaria Parasite in the Western Highlands of Kenya , 2012, Emerging infectious diseases.
[9] O. Doumbo,et al. Mosquito Feeding Assays to Determine the Infectiousness of Naturally Infected Plasmodium falciparum Gametocyte Carriers , 2012, PloS one.
[10] Teun Bousema,et al. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control , 2012, Nature Communications.
[11] S. Hoffman,et al. Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue , 2011, Proceedings of the National Academy of Sciences.
[12] T. Wellems,et al. The threat of artemisinin-resistant malaria. , 2011, The New England journal of medicine.
[13] T. Déirdre Hollingsworth,et al. The Potential Contribution of Mass Treatment to the Control of Plasmodium falciparum Malaria , 2011, PloS one.
[14] Teun Bousema,et al. Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and Elimination , 2011, Clinical Microbiology Reviews.
[15] M. Riehle,et al. A Cryptic Subgroup of Anopheles gambiae Is Highly Susceptible to Human Malaria Parasites , 2011, Science.
[16] Ogobara K. Doumbo,et al. A Research Agenda to Underpin Malaria Eradication , 2011, PLoS medicine.
[17] Elizabeth Ashley,et al. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial , 2010, The Lancet. Infectious diseases.
[18] Wes Hinsley,et al. Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies , 2010, PLoS medicine.
[19] T. Bousema,et al. In Tanzania, Hemolysis after a Single Dose of Primaquine Coadministered with an Artemisinin Is Not Restricted to Glucose-6-Phosphate Dehydrogenase-Deficient (G6PD A−) Individuals , 2010, Antimicrobial Agents and Chemotherapy.
[20] F. Ou,et al. Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine , 2010, Malaria Journal.
[21] T. Bousema,et al. Substantial Contribution of Submicroscopical Plasmodium falciparum Gametocyte Carriage to the Infectious Reservoir in an Area of Seasonal Transmission , 2009, PloS one.
[22] K. Silamut,et al. Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.
[23] I. Versteeg,et al. A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya , 2008, Malaria Journal.
[24] A. Ghani,et al. Modelling the Impact of Artemisinin Combination Therapy and Long-Acting Treatments on Malaria Transmission Intensity , 2008, PLoS medicine.
[25] H. Babiker,et al. A Randomized Open-Label Trial of Artesunate- Sulfadoxine-Pyrimethamine with or without Primaquine for Elimination of Sub-Microscopic P. falciparum Parasitaemia and Gametocyte Carriage in Eastern Sudan , 2007, PloS one.
[26] T. Bousema,et al. Primaquine Clears Submicroscopic Plasmodium falciparum Gametocytes that Persist after Treatment with Sulphadoxine-Pyrimethamine and Artesunate , 2007, PloS one.
[27] Ernest Beutler,et al. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. , 2007, The American journal of tropical medicine and hygiene.
[28] B. Tekwani,et al. 8-Aminoquinolines: future role as antiprotozoal drugs , 2006, Current opinion in infectious diseases.
[29] A. Muñoz,et al. Use of area under the curve to characterize transmission potential after antimalarial treatment. , 2006, The American journal of tropical medicine and hygiene.
[30] Umberto D'Alessandro,et al. Variation in malaria transmission intensity in seven sites throughout Uganda. , 2006, The American journal of tropical medicine and hygiene.
[31] R. Hallett,et al. Chloroquine/Sulphadoxine-Pyrimethamine for Gambian Children with Malaria: Transmission to Mosquitoes of Multidrug-Resistant Plasmodium falciparum , 2006, PLoS clinical trials.
[32] Petra Schneider,et al. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. , 2006, The Journal of infectious diseases.
[33] T. Bousema,et al. (Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate. , 2006, International journal for parasitology.
[34] H. Babiker,et al. Increased density but not prevalence of gametocytes following drug treatment of Plasmodium falciparum. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[35] M. Coosemans,et al. Behavioural heterogeneity of Anopheles species in ecologically different localities in Southeast Asia: a challenge for vector control , 2005, Tropical medicine & international health : TM & IH.
[36] Petra Schneider,et al. Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification. , 2004, Molecular and biochemical parasitology.
[37] A. Talman,et al. Gametocytogenesis : the puberty of Plasmodium falciparum , 2004, Malaria Journal.
[38] Nicholas J. White,et al. Activities of Artesunate and Primaquine against Asexual- and Sexual-Stage Parasites in Falciparum Malaria , 2004, Antimicrobial Agents and Chemotherapy.
[39] C. Drakeley,et al. Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short‐lived reduction in infectiousness for mosquitoes , 2004, Tropical medicine & international health : TM & IH.
[40] C. Drakeley,et al. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. , 2001, The Journal of infectious diseases.
[41] B. Hall,et al. A Model for Sequestration of the Transmission Stages of Plasmodium falciparum: Adhesion of Gametocyte-Infected Erythrocytes to Human Bone Marrow Cells , 2000, Infection and Immunity.
[42] W. Metzger,et al. Reliability of malaria microscopy in epidemiological studies: results of quality control , 2000, Tropical medicine & international health : TM & IH.
[43] P. Ambroise‐Thomas,et al. High human malarial infectivity to laboratory-bred Anopheles gambiae in a village in Burkina Faso. , 1993, The American journal of tropical medicine and hygiene.
[44] P. Reeve,et al. Acute intravascular haemolysis in Vanuatu following a single dose of primaquine in individuals with glucose-6-phosphate dehydrogenase deficiency. , 1992, The Journal of tropical medicine and hygiene.
[45] A. Kaneko,et al. Gametocytocidal effect of primaquine in a chemotherapeutic malaria control trial in North Sumatra, Indonesia. , 1989, The Southeast Asian journal of tropical medicine and public health.
[46] T. Harinasuta,et al. Effect of a single dose of primaquine on a Thai strain of Plasmodium falciparum. , 1980, The Southeast Asian journal of tropical medicine and public health.
[47] R. Sinden,et al. Plasmodium falciparum gametocytes: their longevity and infectivity , 1977, Parasitology.
[48] Margaret Mitchell,et al. Brief Report: Special Modifications of the Fluorescent Screening Method for Glucose-6-Phosphate Dehydrogenase Deficiency , 1968 .
[49] L. Charles. Observations on the haemolytic effect of primaquine in 100 Ghanaian children. , 1960, Annals of tropical medicine and parasitology.
[50] M. D. Young,et al. The treatment of Plasmodium falciparum infection with chloroquine, with a note on infectivity to mosquitoes of primaquine- and pyrimethamine-treated cases. , 1956, American journal of hygiene.
[51] M. Mackerras,et al. Observations on the action of quinine, atebrin and plasmoquine on the gametocytes of Plasmodium falciparum. , 1949, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[52] A. Robertson,et al. The Structure and Development of Plasmodium falciparum Gametocytes in the Internal Organs and Peripheral Circulation. , 1935 .
[53] Andrea K. Knittel,et al. Open Access RESEARCH , 2010 .
[54] M. Laufer. Monitoring antimalarial drug efficacy: Current challenges , 2009, Current infectious disease reports.
[55] Organización Mundial de la Salud. Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations , 2008 .
[56] A. Lensen,et al. Plasmodium falciparum: infectivity of cultured, synchronized gametocytes to mosquitoes. , 1999, Experimental parasitology.
[57] M. Smalley,et al. The distribution of Plasmodium falciparum in the peripheral blood and bone marrow of Gambian children. , 1981, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[58] E. Beutler,et al. Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. , 1968, Blood.
[59] K. Rieckmann,et al. Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum. , 1968, Bulletin of the World Health Organization.
[60] R. W. Burgess,et al. The effect of a single dose of primaquine on the gametocytes, gametogony and sporogony of Laverania falciparum. , 1961, Bulletin of the World Health Organization.
[61] A. Gunders. The effect of a single dose of pyrimethamine and primaquine in combination upon gametocytes and sporogony of Laverania falcipara (Plasmodium falciparum) in Liberia. , 1961, Bulletin of the World Health Organization.
[62] A. Tarlov,et al. Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report. , 1960, Bulletin of the World Health Organization.
[63] J. W. Field,et al. The Microscopic Diagnosis of Human Malaria. II. A Morphological Study of the Erythroeytic Parasites. , 1956 .
[64] J. W. Field,et al. A morphological study of the erythrocytic parasites , 1956 .